Skip to content
10-Q

Quarterly Report

PLx Pharma Winddown Corp.

0001437749-22-020233

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 9, 2022 28.17M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$34.99M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$9.76M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $35.73M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $69.39M
Stockholders Equity Q2 2022 · Jun 30, 2022 $16.49M
Stockholders Equity Q2 2022 · Mar 31, 2022 $25.97M
Stockholders Equity Q2 2022 · Dec 31, 2021 $35.67M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 $40.12M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 $44.66M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 −$10.93M
Current Liabilities Q2 2022 · Jun 30, 2022 $9.07M
Current Liabilities Q2 2022 · Dec 31, 2021 $11.88M
Total Liabilities Q2 2022 · Jun 30, 2022 $12.04M
Total Liabilities Q2 2022 · Dec 31, 2021 $24.96M
Current Assets Q2 2022 · Jun 30, 2022 $41.48M
Current Assets Q2 2022 · Dec 31, 2021 $73.48M
Total Assets Q2 2022 · Jun 30, 2022 $44.54M
Total Assets Q2 2022 · Dec 31, 2021 $76.64M
Eps Basic Q2 2022 · Jun 30, 2022 −$0.43
Eps Basic Q2 2022 · Jun 30, 2022 −$0.82
Eps Basic Q2 2022 · Jun 30, 2021 −$0.79
Eps Basic Q2 2022 · Jun 30, 2021 −$1.53
Sga Expense Q2 2022 · Jun 30, 2022 $13.65M
Sga Expense Q2 2022 · Jun 30, 2022 $32.1M
Sga Expense restated Q2 2022 · Jun 30, 2021 $5.5M
Sga Expense restated Q2 2022 · Jun 30, 2021 $8.13M
Rd Expense Q2 2022 · Jun 30, 2022 $556K
Rd Expense Q2 2022 · Jun 30, 2022 $1.21M
Rd Expense restated Q2 2022 · Jun 30, 2021 $983K
Rd Expense restated Q2 2022 · Jun 30, 2021 $1.94M
Net Income Q2 2022 · Jun 30, 2022 −$11.86M
Net Income Q2 2022 · Jun 30, 2022 −$22.64M
Net Income Q2 2022 · Mar 31, 2022 −$10.79M
Net Income restated Q2 2022 · Jun 30, 2021 −$16.51M
Net Income restated Q2 2022 · Jun 30, 2021 −$28.05M
Net Income restated Q2 2022 · Mar 31, 2021 −$11.54M
Operating Income Q2 2022 · Jun 30, 2022 −$14.54M
Operating Income Q2 2022 · Jun 30, 2022 −$32.73M
Operating Income restated Q2 2022 · Jun 30, 2021 −$6.48M
Operating Income restated Q2 2022 · Jun 30, 2021 −$10.08M
Gross Profit Q2 2022 · Jun 30, 2022 −$337K
Gross Profit Q2 2022 · Jun 30, 2022 $577K
Gross Profit Q2 2022 · Jun 30, 2021 $0
Gross Profit Q2 2022 · Jun 30, 2021 $0
Cost Of Revenue Q2 2022 · Jun 30, 2022 $820K
Cost Of Revenue Q2 2022 · Jun 30, 2022 $1.99M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0